Table of Contents
Chapter 1. Global Travel Vaccines Market Executive Summary
1.1. Global Travel Vaccines Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Disease
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Travel Vaccines Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Travel Vaccines Market Dynamics
3.1. Market Drivers
3.1.1. Increased International Travel
3.1.2. Rising Awareness About Vaccine-Preventable Diseases
3.1.3. Governmental Travel Regulations
3.2. Market Challenges
3.2.1. High Costs of Vaccine Development
3.2.2. Strict Regulatory Requirements
3.2.3. Cold Chain Logistics
3.3. Market Opportunities
3.3.1. Development of Vaccines for Emerging Infectious Diseases
3.3.2. Expansion of Travel Vaccine Portfolio
3.3.3. Public-Private Partnerships for Vaccine R&D
Chapter 4. Global Travel Vaccines Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Travel Vaccines Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Travel Vaccines Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Attenuated Vaccines
5.2.2. Conjugate Vaccines
5.2.3. DNA Vaccines
5.2.4. Inactive Vaccines
5.2.5. Recombinant Vector Vaccines
5.2.6. Subunit Vaccines
5.2.7. Toxoid Vaccines
Chapter 6. Global Travel Vaccines Market Size & Forecasts by Disease 2022-2032
6.1. Segment Dashboard
6.2. Global Travel Vaccines Market: Disease Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. DPT
6.2.2. Hepatitis A
6.2.3. Hepatitis B
6.2.4. Japanese Encephalitis
6.2.5. Measles and Mumps
6.2.6. Meningococcal
6.2.7. Rabies
6.2.8. Typhoid
6.2.9. Varicella
6.2.10. Yellow Fever
Chapter 7. Global Travel Vaccines Market Size & Forecasts by Region 2022-2032
7.1. North America Travel Vaccines Market
7.1.1. U.S. Travel Vaccines Market
7.1.1.1. Type breakdown size & forecasts, 2022-2032
7.1.1.2. Disease breakdown size & forecasts, 2022-2032
7.1.2. Canada Travel Vaccines Market
7.2. Europe Travel Vaccines Market
7.2.1. U.K. Travel Vaccines Market
7.2.2. Germany Travel Vaccines Market
7.2.3. France Travel Vaccines Market
7.2.4. Spain Travel Vaccines Market
7.2.5. Italy Travel Vaccines Market
7.2.6. Rest of Europe Travel Vaccines Market
7.3. Asia-Pacific Travel Vaccines Market
7.3.1. China Travel Vaccines Market
7.3.2. India Travel Vaccines Market
7.3.3. Japan Travel Vaccines Market
7.3.4. Australia Travel Vaccines Market
7.3.5. South Korea Travel Vaccines Market
7.3.6. Rest of Asia Pacific Travel Vaccines Market
7.4. Latin America Travel Vaccines Market
7.4.1. Brazil Travel Vaccines Market
7.4.2. Mexico Travel Vaccines Market
7.4.3. Rest of Latin America Travel Vaccines Market
7.5. Middle East & Africa Travel Vaccines Market
7.5.1. Saudi Arabia Travel Vaccines Market
7.5.2. South Africa Travel Vaccines Market
7.5.3. Rest of Middle East & Africa Travel Vaccines Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Abbott Laboratories
8.1.2. AstraZeneca PLC
8.1.3. Bavarian Nordic A/S
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. AstraZeneca PLC
8.3.3. Bavarian Nordic A/S
8.3.4. Bharat Biotech Ltd.
8.3.5. Bio-Manguinhos
8.3.6. Bio-Med (P) Limited
8.3.7. Biological E Limited
8.3.8. Cadila Pharmaceuticals Limited
8.3.9. CSL Limited
8.3.10. Dano Vaccines & Biologicals Private Limited
8.3.11. Dynavax Technologies Corporation
8.3.12. Emergent BioSolutions Inc.
8.3.13. GlaxoSmithKline PLC
8.3.14. Incepta Pharmaceuticals Ltd.
8.3.15. Indian Immunologicals Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes